Open AccessCost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis
Author(s) -
Jas Bindra,
Ishveen Chopra,
John Niewoehner,
Mary P Panaccio,
George J. Wan
Publication year - 2021
Publication title -
clinicoeconomics and outcomes research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.591
H-Index - 27
ISSN - 1178-6981
DOI - 10.2147/ceor.s304600
Subject(s) - medicine , rheumatoid arthritis , quality of life (healthcare) , quality adjusted life year , cost effectiveness , physical therapy , pediatrics , risk analysis (engineering) , nursing
Patients with active rheumatoid arthritis (RA) often have inadequately controlled symptoms and are unable to achieve remission or low disease activity despite aggressive treatment. This results in irreversible joint damage, adversely affecting patients' physical and social functioning. The objective was to estimate the cost-effectiveness of repository corticotropin injection (RCI) versus standard of care (SoC) in patients with active RA from the United States (US) payer and societal perspectives over two to three years.